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An 8 month old girl presented with undiagnosed non-
anatomic congenital cardiomyopathy with massive car-
diomegaly on chest Xvray film. Her older sibling had
died suddenly at 6 months of age from what appeared
to be a similar abnormality. Utilizingphosphorus-31 nu-
clear magnetic resonance (P-31 NMR) surface coil spec-
troscopy, a metabolic disorder was demonstrated in both
her myocardium and skeletal muscle, revealing a phos-
phocreatine (PCr) to inorganic phosphate (Pi) ratio of
half of that for a normal control infant. Manipulation
of serum substrate availability indicated that medium
chain triglycerides alone did not improve myocardial
Recent advances in phosphorus-31 (P-31) nuclear magnetic
resonance (NMR) spectroscopy suggest that P-31 nuclear
magnetic resonance may be very useful as a 'noninvasive
monitor for studying metabolic disturbances in human beings.
The ability of nuclear magnetic resonance to sequentially
and noninvasively assess tissue metabolism has recently
been applied as a diagnostic tool to evaluate human skeletal
muscle disease, particularly genetic deficiencies (1-4) .
An 8 month old female infant was referred with a di-
agnosis of familial hypertrophic cardiomyopathy . Her heart
was estimated as approximately three times normal size .
The purpose of this study was to determine: l) if P-31
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metabolism, but that intravenous glucose or oral car-
bohydrate loading raised the myocardial PCr/Pi ratio
from 1.0 ± 0.05 to 1.8 ± 0.1 (p < 0.01) without sig-
nificantly affecting the PCr/Pi value of her resting skel-
etal muscle.
This study demonstrates the feasibility of using P-31
nuclear magnetic resonance to evaluate the biochemistry
of the human myocardium in vivo and to diagnose a
metabolic abnormality. Phosphorus-J! nuclear mag-
netic resonance can thus be used to optimize therapy for
human disease.
(J Am Coil CardioI1985;5:745-9)
nuclear magnetic resonance of human myocardium was fea-
sible; 2) whether P-3l nuclear magnetic resonance could
detect a metabolic abnormality in human myocardium; and
3) whether P-31 nuclear magnetic resonance could be used
to optimize therapeutic interventions designed to improve
myocardial energy production. This patient represented an
ideal study subject in that I) her heart to chest volume ratio
and heart wall thickness was such that we could expect an
excellent signal response from her myocardium; and 2) as
an infant , skeletal muscle development was minimal and
unlikely to contribute significantly to her cardiac nuclear
magnetic resonance scan.
Case Presentation
An 8 month old girl presented with cardiomegaly . The
electrocardiogram revealed biventricular hypertrophy with-
out evidence of myocardial ischemia or failure . The patient's
older sister had died suddenly at the age of 6 months. At
autopsy, she had massive cardiomegaly with an apparent
increase in myocardial mitochondrial content.
Metabolic studies. These showed I) a hyperchloremic
metabolic acidosis; 2) normal ketogenesis after a medium
chain triglyceride load; 3) a mildly elevated beta-hydroxy
0735-1097/85/$3.30
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Figure 1. Phosphorus-31 nuclear mag-
netic resonance spectra generated at 1.9
Tesla from the quadriceps (A) and heart
(B) of an 18 month old healthy child.
Inorganic phosphate (Pi), phosphocrea-
tine (PCr) and gamma- (1), alpha- (a) and
beta- (f3) adenosine triphosphate (ATP)
peaks are readily distinguishable. Note the
difference in the PCr/Pi ratios in skeletal
muscle at rest versus the working heart.
Spectra represent 100 signal-averaged
freeinduction decays. A spectral width of
3,000 Hz was used with a line broadening
of 10 Hz. The dashed line is computer-
generated fit to data (see Fig. 4). PDE =
phosphate diesters; PME = phosphate
monoesters.
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butyrate/acetoacetate ratio (2.2: 0.5), as well as an elevated
lactate/pyruvate ratio (1.8-2.7:0.03-0.08); 4) a normal in-
travenous glucose tolerance test; and 5) fasting hypogly-
cemia (40 mgllOO ml at 12 hours) without an increase in
free fatty acids or ketogenesis.
, These studies suggested the possibilities of I) a defect in
the utilization of long chain fatty acids as fuel during a fast;
2) a defect in gluconeogenesis; and 3) abnormal mitochon-
drial metabolic function.
Methods
Phosphorus-31 nuclearmagnetic resonance spectros-
copy of human myocardium. The patient or control sub-
ject was placed in a 1.9 Tesla, 26.7 cm bore superconducting
magnet (Oxford Research Systems) with the sternum or
quadriceps directly over a surface coilS cm in diameter.
Nuclear magnetic resonance spectra such as shown in Figure
1 were recorded at 32.5 MHz. Data collection was accom-
plished with 100 to 200 radiofrequency pulses applied every
3 seconds. A spectral width of 3,000 Hz was used with a
line broadening of 10 Hz. The pulse width was empirically
optimized using a phosphorus phantom (25 mm). The "con-
trol" subject was a healthy 18 month old boy.
Evaluation of dietary manipulation. Nuclear magnetic
resonance data were obtained intermittently during a 4 day
period of dietary and circulating substrate manipulation. On
day 1, a spectrum of the patient's quadriceps muscle and
heart (Fig. 2) were obtained 4 to 6 hours after eating the
control high glucose, high medium chain triglyceride diet.
On day 2, cardiac spectra were obtained after an 8 hour
fast, 2 to 4 hours after nasogastric administration of medium
chain triglycerides (IS ml) and then 30 minutes after intra-
venous administration of glucose (l.5 g/kg over 10 minutes).
On day 3, the child was fed at 3 to 4 hour intervals. Four
hours after the third feeding, the patient was given intra-
venous glucose (0.5 g/kg over 10 minutes). The child awoke
and moved about interfering with the data collection. Thus
only IS minute and 60 to 80 minute postintravenous glucose
scans were obtained.
On day 4, a baseline scan was obtained after an 8 hour
fast (Fig. 3A). Intravenous glucose (0.5 g/kg over 10 min-
utes) was given and scans obtained every 5 minutes for 85
minutes (Fig. 3B). The child was then fed at 3 hour intervals
and measured 60 to 90 minutes after the second feeding
(Fig. 3C). These manipulations covering several days seem
necessary for an understanding of dietary control of tissue
metabolic activities.
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Figure 2. Phosphorus-31 nuclear mag-
netic resonance spectra from the quadri-
ceps (A) and heart (B) of an 8 month old
infant girl with cardiomyopathy. Note that
in both her skeletal muscle as well as her
heart, she has a profound depression in
her phosphocreatine/inorganic phosphate
(PCr/Pi) ratio. The abnormality in her
skeletal muscle detected by nuclear mag-
netic resonance was not appreciated clin-
ically (spectra were generated as in Fig.
1). The dashed line is computer-gener-
ated fit to data (see Fig. 4). Other abbre-
viations as in Figure 1.
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raw data. This value was expected to reflect changes in
absolute phosphocreatine concentration since adenosine tri-
phosphate concentration has been found to be constant in
animal models under similar conditions. The pulse repetition
interval (3 seconds) was chosen to give an optimal signal
to noise ratio. No corrections to peak areas for partial sat-
uration were made. All errors are expressed as a standard
error of the mean. All comparisons were made using the
Student's nonpaired t test.
Results
IB
Figure 3. Phosphorus-31 nuclear magnetic resonance spectra from
the patient's myocardium (200 signal-averaged free induction de-
lays). A, Baseline spectrum. B, Thirty minutes after intravenous
(LV.) glucose administration (500 mg/kg). Note the increase in
the phosphocreatine peak and the return of the phosphocreatine to
inorganic phosphate (PCr/Pi ) ratio toward control levels (Fig. 1).
C, During the absorptive phase of a high glucose meal. Again,
note the improvement in the PCr/P i ratio to virtually control levels
(Fig. I). Abbreviations as in Figure 1.
Discussion
Surface coil spectroscopy. The human heart seems
ideally suited for examination by surface coil nuclear mag-
netic resonance (NMR). The human sternum is flat and
provides an NMR-Iucent window through which it was pos-
sible to examine the cardiac high energy phosphate profile
in the case of the patient with cardiac hypertrophy, with
wall thickness of more than 1 em as determined at autopsy.
The radiofrequency surface coil may be placed over the
body of the sternum away from rectus abdominus and in-
tercostal muscle. Surface coil cardiac spectroscopy in ani-
mal models show virtually identical phosphocreatine/
inorganic phosphate (PCr/P;) and phosphocreatine/adeno-
sine triphosphate (PCr/ATP) ratios in closed versus open
chest dogs (5), these spectra being markedly different from
skeletal muscle scans. In our subjects, the skeletal (quad-
riceps) muscle also appeared substantially different from the
myocardium (Fig. I and 2). Contamination of the cardiac
spectra by skeletal muscle signal is minimal and poses neg-
ligible difficulties in interpretation. Surface coil P-31 nu-
clear magnetic resonance spectroscopy of human myocar-
dium thus appears feasible (Fig. 1).
Myocardial bioenergetics. The ability of tissue to meet
its energy requirements by oxidative metabolism can be
The phosphocreatine/inorganic phosphate (PCr/Pi) ratio
in the control subject's myocardium was 2.0 ± 0.3, and
7.4 in his skeletal muscle. The PCr/ATP ratio in his heart
was 2.0 ± 0.1.
The patient's baseline myocardial PCr/P i ratio was 1.0
± 0.05 (p < 0.01 versus control) and the skeletal PCr/Pi
ratio was 3.4. Medium chain triglyceride administration
failed to improve the patient's PCr/Pi ratio (0.9 ± O. 1, not
significant versus baseline level). However, both intrave-
nous glucose and a high glucose-medium chain triglyceride
meal raised the myocardial PCr/Pi ratio to 1.8 ± 0.1 (p <
0.01 versus baseline level, not significant versus control)
(Fig. 5). PCr/ATP ratios confirmed this improvement in high
energy phosphate production with ratios improving from
1.3 ± 0.1 to 2.0 ± 0.1 (p < 0.01). Skeletal muscle scans
obtained after glucose administration failed to show any
improvement in high energy phosphate production.
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Spectral analysis. Quantitation of metabolic compo-
nents was obtained from the nuclear magnetic resonance
spectra by peak area estimations and by using a computer
curve-fitting routine (Fig. 4). In this way phosphocrea-
tine/inorganic phosphate (PCr/P;) ratios were determined at
baseline (4 to 8 hours postprandial), 2 to 4 hours after
medium chain triglyceride loading (at a time when the pa-
tient would have maximal ketogenesis), 15 to 60 minutes
after intravenous glucose administration and 60 to 90 min-
utes after an oral high carbohydrate-medium chain triglyc-
eride meal (at a time corresponding to maximal absorption).
The ratio of the phosphocreatine (PCr) peak area to the
adenosine triphosphate (ATP) peak area was determined
using measured peak heights and widths derived from the
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Figure 4. Graphic illustration of computer spec-
tral curve fit which utilizes a function minimiza-
tion routine to generate a " best fit" for the raw
spectrum. The solid line shows the raw spectrum,
the dotted line the best fit and the dashed line
the component peaks of best fit. Phosphocrea-
tine/inorganic phosphate (PCr/Pi ) ratios were de-
termined from the areas under the respective com-
ponent peaks. Abbreviations as in Figure I .
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assessed by the phosphocreatine/inorganic phosphate (Per/Pi)
ratio (6-8) . As the ratio decreases to I, the mitochondria
approach the maximal rate of aerobic energy production.
Example s of this are found in this study where the normal
skeletal muscle at rest has a PCr/P i ratio of approximately
7.4 , whereas the myocardium , which is metabolically much
more active, has a ratio of approximately 2.0 (Fig. I). Our
Per/ATP ratio of 2.0 ± 0.1 is close to recent values (Per/ATP
= I. 7 in the right ventricle ) obtained by Kantor et al. (9)
by a catheter nuclear magnetic resonance probe inserted into
the endocardium of an animal heart . Thus, our external
noninvasive value agrees with the value obtained with an
invasive catheter in an animal model.
The pathologic state of our patient is evident by her
baseline myocardial PCr/P i ratio of 1.0 , indicating that her
cardiac metabolism is operating at the maximal ratio and
could be at the brink of being unable to aerobically meet
energy demands . Surface coil P-31 nuclear magnetic res-
onance spectroscopy allowed us to noninvasively optimize
a dietary therapy designed to improve her myocardial energ y
balance .
The rationale of this study may be a prototype for others
(10) where baseline data for starved , fed and therapeutically
altered metabolic states are explored for their favorable im-
pact on specific organ energy metaboli sm. Most important
is the ability of P-31 nuclear magnetic resonance to follow
continuously these trends in metaboli sm and to ensure that
a stable state of improvement is achieved in experimental
therapeutics.
Future trends. The application of P-31 nuclear mag-
netic resonance to human cardiomyopathy is new; hereto-
fore, it has only been used in skeletal muscle. Nuclear
magnetic resonance evaluation in the adult focuses mainly
on generating images based on the proton. One of the main
reasons for this is that while protons have a concentration
of approximately 100 M, phosphorus metabolites have a
cellular concentration on the order of 10 mM. Consequently,
magnets must be significantly stronger and scanning times
longer to detect a phosphorus signal. Present day technolog y
has not solved the problem of generating adequate field
strengths in magnets large enough to accommodate the adult
thorax so as to generate phosphorus spectra in a reasonable
time frame . However, high field magnets like the one uti-
lized in this study , although 10 to 20 times stronger than
the typical clinical imaging magnet , are large enough to
allow the young pediatric patient to undergo P-31 nuclear
magnetic resonance evaluation, whether it be of the brain
(II ), liver (12) or heart. In the near future, it will be this
age group that will undergo the most intensive evaluation
of visceral bioenergetics.
We thank Mr. and Mrs. Paul Pedrotti. parents of the child , for being so
understanding and cooperati ve during this study, and John S. Leigh, Jr. ,
PhD for the time and effort he gave us in reviewing this manuscript.
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